In Vitro Fertilization IVF Workstations

In Vitro Fertilization IVF Workstations Market Outlook

The global In Vitro Fertilization (IVF) Workstations market is projected to reach approximately USD 2.5 billion by 2035, growing at a robust compound annual growth rate (CAGR) of around 7.8% during the forecast period from 2025 to 2035. This growth trajectory is driven primarily by the increasing prevalence of infertility issues, escalating demand for advanced reproductive technologies, and a rising number of fertility clinics and hospitals specializing in assisted reproductive services. Furthermore, technological advancements in IVF workstations, enabling better outcomes and higher success rates in assisted reproduction, significantly contribute to market expansion. The growing awareness about reproductive health and the acceptance of IVF as a viable solution for infertility challenges are also pivotal factors bolstering this market. The demographic shifts towards delayed parenthood are creating a fertile ground for the IVF workstations market to flourish.

Growth Factor of the Market

Several factors play a crucial role in propelling the growth of the IVF workstations market. Firstly, the increasing incidence of infertility problems globally, attributed to lifestyle changes and medical conditions, is urging couples to seek assisted reproductive technologies. Secondly, advancements in medical technology, such as the development of sophisticated incubation systems and imaging technologies, have significantly improved the success rates of IVF procedures. Thirdly, the government initiatives and funding aimed at promoting reproductive health services also contribute to the market growth, particularly in developing regions. Furthermore, the rising trend of surrogacy and egg freezing, which are closely associated with IVF technologies, is creating a larger market for IVF workstations. Lastly, patient education regarding reproductive health and the availability of financial assistance programs are also enhancing the market’s growth potential.

Key Highlights of the Market

• The market is anticipated to witness a CAGR of 7.8% from 2025 to 2035.
• North America is expected to hold the largest share of the market due to advanced healthcare infrastructure.
• Technological advancements, particularly in imaging and incubation systems, are driving innovation.
• Fertility clinics are anticipated to be the primary application area for IVF workstations.
• Growing awareness about infertility treatments is fostering acceptance and utilization of IVF services.

By Product Type

Suction Pumps:

Suction pumps are essential components in IVF workstations as they play a critical role in the oocyte retrieval process. These devices facilitate the aspiration of follicular fluid from the ovaries, allowing for the collection of oocytes to be used in fertilization procedures. The market for suction pumps is driven by technological advancements that enhance their efficiency, such as automated systems that reduce the risk of human error. Additionally, the increasing number of IVF cycles performed globally underlines the necessity for reliable suction pumps, further contributing to the market's growth. As clinics strive to improve their success rates, the demand for high-quality and efficient suction pumps is expected to rise, solidifying their position within the IVF workstations market.

Incubators:

Incubators are vital for maintaining optimal conditions for embryo development during the IVF process. The market for incubators has evolved with the introduction of advanced technologies that allow for real-time monitoring and control of environmental parameters such as temperature, humidity, and gas composition. This technological progression has enabled better embryo culture conditions, leading to improved implantation rates and overall success of IVF treatments. The increasing focus on improving embryo viability and the emphasis on personalized embryo culture are driving the demand for advanced incubator systems. Furthermore, the integration of time-lapse technology in incubators allows embryologists to monitor embryo development without disrupting the incubation environment, thus enhancing their efficacy in IVF procedures.

Oocyte Retrieval Needles:

Oocyte retrieval needles are critical instruments used in the IVF process to extract oocytes from follicles. The market for these needles is driven by advancements in needle technology, providing improved precision and reduced trauma during retrieval procedures. Manufacturers are focusing on developing ergonomic designs that enhance usability for clinicians, which is expected to boost adoption rates in fertility clinics and hospitals. Furthermore, the increasing number of IVF treatments and the rise in the prevalence of infertility are anticipated to elevate the demand for high-quality oocyte retrieval needles, contributing to the growth of this specific segment of the IVF workstations market.

Micromanipulator Systems:

Micromanipulator systems play a pivotal role in the IVF process, particularly in procedures such as intracytoplasmic sperm injection (ICSI) and other advanced reproductive technologies. These systems enable precise manipulation of oocytes and embryos, which is crucial for successful fertilization and embryo development. The market for micromanipulator systems is expanding due to technological advancements that have made these systems more user-friendly and efficient. Innovations such as robotic-assisted techniques are enhancing the accuracy of manipulations, thus improving the success rates of IVF treatments. As the demand for sophisticated reproductive technologies continues to rise, micromanipulator systems will likely see substantial growth within the IVF workstations market.

Imaging Systems:

Imaging systems are becoming increasingly important in the IVF process, providing vital information regarding embryo quality and development. The introduction of high-resolution imaging technologies has allowed embryologists to observe embryos closely, which is critical for selecting the best embryos for transfer. With advancements in imaging techniques such as time-lapse imaging, these systems offer non-invasive monitoring of embryo development, enabling clinicians to make informed decisions regarding embryo viability. The growing emphasis on achieving higher success rates in IVF procedures is driving the demand for advanced imaging systems, ensuring their significant role in the IVF workstations market continues to expand.

By Application

Fertility Clinics:

Fertility clinics are one of the primary applications of IVF workstations, as these facilities specialize in assisted reproductive technologies. The increasing number of fertility clinics worldwide, driven by the rising infertility rates and growing awareness of reproductive health, is expected to significantly boost the demand for IVF workstations in this segment. Clinics are continually seeking advanced technologies to enhance their service offerings and improve patient outcomes, resulting in a growing market for sophisticated IVF equipment. As fertility clinics strive to provide personalized care and higher success rates, the demand for innovative IVF workstations will certainly continue to rise, establishing a strong foothold in the overall market.

Hospitals:

Hospitals are vital players in the IVF workstations market, providing a wide range of reproductive health services, including IVF treatments. The integration of IVF services within hospitals allows for comprehensive patient care, combining surgical procedures and assisted reproductive technologies. The growing trend of hospitals offering specialized reproductive health units is expected to drive demand for advanced IVF workstations. Additionally, as healthcare institutions aim to improve their reproductive health services, the investment in state-of-the-art IVF technologies will increase, further solidifying hospitals' role in the expansion of the IVF workstations market.

Research Institutes:

Research institutes focused on reproductive health and fertility are key contributors to the IVF workstations market. These institutions undertake significant research and development activities aimed at advancing IVF techniques and improving reproductive outcomes. The demand for IVF workstations in research facilities is driven by the need for advanced technologies that enable precise experimentation and analysis of reproductive processes. As research institutes continue to innovate and enhance IVF methodologies, their reliance on sophisticated workstations will bolster the market's growth. Furthermore, the collaboration between research institutes and clinical settings fosters the development of new techniques, driving the continuous improvement of IVF technologies.

Cryobanks:

Cryobanks play a crucial role in the IVF workstations market by providing essential services for the preservation of reproductive cells, such as sperm and oocytes. The increasing demand for cryopreservation services, driven by factors such as delayed parenthood and fertility preservation, is expected to fuel the growth of this segment. Cryobanks rely on advanced IVF workstations to maintain optimal storage conditions and facilitate the processing of gametes. As more individuals and couples seek to preserve their fertility, the need for high-quality cryobanks and associated IVF technologies will continue to rise, thereby enhancing the overall market landscape.

By End User

Surgery Centers:

Surgery centers are increasingly becoming important end users of IVF workstations due to the growing trend of outpatient surgeries, including reproductive procedures. These centers provide specialized services that allow patients to undergo IVF treatments in a more accessible environment, leading to enhanced patient satisfaction and reduced costs. The growth of surgery centers is driven by the rising preference for minimally invasive procedures and shorter recovery times associated with IVF treatments. As surgery centers expand their offerings in reproductive health, the demand for advanced IVF workstations is expected to rise, contributing to overall market growth.

Clinics:

Clinics are significant end users of IVF workstations, offering a wide range of reproductive health services, including IVF and fertility assessments. The increasing number of fertility clinics worldwide, driven by heightened awareness of infertility issues and the desire for assisted reproductive technologies, is anticipated to boost the demand for IVF workstations in this segment. Clinics often seek advanced technologies to enhance their service offerings and improve patient outcomes, which drives the need for sophisticated IVF equipment. As the desire for successful reproductive treatments continues to grow, the role of clinics in the IVF workstations market will expand significantly.

Hospitals:

Hospitals serve as crucial end users of IVF workstations, providing comprehensive reproductive health services, including IVF and other assisted reproductive technologies. The integration of IVF services within hospitals facilitates a holistic approach to patient care, combining surgical interventions with advanced reproductive technologies. The rising number of hospitals offering specialized reproductive health services is expected to drive demand for IVF workstations. Furthermore, as healthcare institutions aim to improve their reproductive health services, investments in state-of-the-art IVF technologies will increase, further solidifying hospitals' significant role in the expansion of the IVF workstations market.

Homecare Settings:

Homecare settings are emerging as a vital end user segment in the IVF workstations market due to the increasing trend towards at-home fertility treatments and monitoring. With advances in technology, patients now have access to various tools and kits that allow them to monitor their fertility status from the comfort of their homes. The convenience and personalization offered by homecare solutions are driving their adoption among patients, particularly those who prefer to manage their reproductive health independently. As the market for home fertility solutions continues to expand, the demand for related IVF workstations that support these applications will likely see significant growth.

By Technology

Time-Lapse Technology:

Time-lapse technology has revolutionized the field of IVF by enabling continuous monitoring of embryos during cultivation without disturbing their environment. This technology allows embryologists to capture high-resolution images of embryos at regular intervals, providing valuable insights into their development and facilitating better selection for implantation. The increased successful outcomes resulting from this technology have driven its adoption in IVF workstations, contributing significantly to market growth. As clinics aim to enhance their success rates and improve patient satisfaction, the demand for time-lapse imaging systems will continue to rise, further reinforcing their importance in the IVF workstations market.

EmbryoScope Technology:

EmbryoScope technology, a specialized form of time-lapse monitoring, has gained popularity in IVF workstations due to its advanced capabilities in embryo assessment. This technology offers a controlled environment with real-time imaging, allowing embryologists to closely monitor embryo development without removing them from the incubator. This non-invasive monitoring method helps in identifying the most viable embryos for transfer, significantly increasing the chances of successful implantation. The growing acceptance of embryoScope technology in fertility clinics highlights the critical role it plays in enhancing the success rates of IVF procedures, bolstering its position in the market.

Closed Incubation Systems:

Closed incubation systems are designed to provide a stable and controlled environment for embryos during the IVF process, minimizing the risks of contamination and ensuring optimal development conditions. These systems have gained traction due to their ability to maintain precise temperature, humidity, and gas levels, which are crucial for embryo viability. The increasing focus on improving embryo culture conditions and reducing the risk of exposure to external factors are driving the demand for closed incubation systems in IVF workstations. As clinics prioritize quality and safety in reproductive health, the adoption of advanced closed systems will likely see considerable growth, contributing to the market's overall expansion.

Sequential Media:

Sequential media plays a vital role in the IVF process by providing the necessary nutrients and growth factors for embryo development. The use of sequential media allows for a tailored approach to embryo culture, enabling clinicians to optimize the growth environment based on the specific developmental needs of the embryos. The increasing emphasis on improving embryo viability and success rates in IVF treatments is driving the demand for high-quality sequential media. As advancements continue to be made in this area, the adoption of innovative media solutions will likely contribute to the expanding market for IVF workstations.

By Region

The regional landscape of the IVF workstations market reveals significant variations in growth trajectories and market dynamics. North America currently holds the largest market share, valued at approximately USD 1 billion in 2025, driven by well-established healthcare infrastructure, high awareness regarding reproductive health, and advanced technological capabilities. In this region, the CAGR is estimated to be 7.2% during the forecast period, reflecting the increasing number of fertility clinics and the growing acceptance of IVF treatments among the population. Europe follows closely, with a projected market size of around USD 800 million by 2025, supported by robust healthcare policies and a rising prevalence of infertility treatments.

In the Asia Pacific region, the IVF workstations market is poised for considerable growth, with a projected CAGR of 9.1% during the forecast period. This growth is fueled by the increasing investments in healthcare infrastructure, rising disposable incomes, and burgeoning awareness of assisted reproductive technologies. Countries such as China and India are experiencing rapid growth in the number of fertility clinics and hospitals offering IVF services, thus driving the demand for advanced workstations. Meanwhile, the Latin American and Middle East & Africa regions are expected to witness steady growth, although their market sizes remain relatively smaller compared to North America and Europe. The overall regional analysis indicates a dynamically evolving market, with North America and Europe leading while emerging economies in Asia Pacific present significant growth opportunities.

Opportunities

The IVF workstations market presents numerous opportunities for growth, particularly in emerging economies where reproductive health services are becoming increasingly accessible. As awareness of infertility and assisted reproductive technologies continues to rise, there is a growing demand for high-quality IVF services in regions such as Asia Pacific and Latin America. These markets offer significant potential for clinics and hospitals to expand their IVF service offerings, thereby driving the demand for advanced workstations. Additionally, the rise in government initiatives aimed at improving reproductive health services and funding for fertility treatments is likely to create further opportunities for growth within these regions. The ongoing advancements in technology, such as the integration of artificial intelligence and machine learning in IVF procedures, also present avenues for innovation and development in this sector.

Moreover, collaborations between hospitals, fertility clinics, and research institutions are expected to yield significant advancements in reproductive technologies and IVF methodologies. Such partnerships can lead to the development of novel solutions that enhance the efficacy of IVF treatments, thereby increasing the competitive landscape for IVF workstations. Furthermore, as patients become increasingly informed about their reproductive health options, there is a growing inclination towards personalized and tailored treatments, which can create opportunities for specialized IVF workstations designed to meet specific patient needs. Overall, the combination of rising awareness, technological advancements, and collaborative efforts presents a plethora of opportunities for growth in the IVF workstations market.

Threats

Despite the promising growth prospects for the IVF workstations market, there are several threats that could impede its progress. One significant threat is the high cost associated with advanced IVF technologies, which can limit accessibility for patients, particularly in developing regions. The expenses related to the procurement and maintenance of sophisticated IVF workstations may deter clinics from investing in these technologies, potentially restricting market growth. Additionally, the rising prevalence of regulatory scrutiny and compliance requirements in reproductive healthcare can pose challenges for manufacturers and providers operating in this sector. The need to adhere to stringent standards may slow down the introduction of new products and innovations, impacting the overall market dynamics.

Furthermore, the ongoing global healthcare challenges, such as the COVID-19 pandemic, have disrupted the supply chains of medical equipment and technologies, affecting the availability of IVF workstations and related components. Such disruptions can lead to delays in treatments and impact the overall patient experience. Lastly, competition from alternative reproductive technologies, such as natural cycle IVF and the increasing popularity of fertility medications, may pose risks to the traditional IVF workstations market. As patients seek less invasive and more cost-effective options, the demand for conventional IVF technologies could face significant challenges. Overall, these threats necessitate strategic planning and adaptability from industry participants to navigate the evolving landscape effectively.

Competitor Outlook

• CooperSurgical Inc.
• Vitrolife AB
• Ferring Pharmaceuticals
• Merck KGaA
• Cook Medical
• IBSA Farmaceutici Italia Srl
• Thermo Fisher Scientific Inc.
• Genea Biomedx
• Hologic Inc.
• ESCO Micro Pte Ltd.
• K-ART Clinic
• LifeGlobal
• ReproMed Ltd.
• Swiss Fertility Centre
• Fertility Partners

The competitive landscape of the IVF workstations market is characterized by the presence of numerous players specializing in reproductive technologies and equipment. These companies are continually innovating to develop advanced solutions that enhance the efficiency and success rates of IVF procedures. The competitive dynamics are influenced by factors such as technological advancements, the introduction of novel products, and strategic partnerships among industry participants. Companies are also focusing on expanding their geographical reach and increasing their market share by targeting emerging markets, where the demand for IVF services is on the rise. As competition intensifies, organizations need to differentiate themselves through innovation and superior customer service to maintain a competitive edge in the market.

CooperSurgical Inc. is a notable player in the IVF workstations market, offering a comprehensive range of products designed to support assisted reproductive technologies. The company's commitment to research and development ensures that it remains at the forefront of innovation in reproductive health. Vitrolife AB is another key competitor known for its advanced embryo culture media and IVF equipment, helping clinics improve their success rates. The company's focus on quality and performance has established it as a trusted name in the industry. Merck KGaA, a global leader in the life sciences sector, also plays a significant role in the IVF workstations market, providing innovative solutions that enhance reproductive healthcare outcomes.

Thermo Fisher Scientific Inc. is a prominent player, known for its extensive offerings in laboratory equipment and technologies, including IVF workstations. The company's commitment to advancing reproductive health technologies is evident in its continuous investment in product development. Hologic Inc. is recognized for its advanced imaging systems that enhance embryo monitoring during the IVF process, showcasing its expertise in reproductive technologies. Moreover, the growing collaborations among these companies and research institutions are fostering advancements in IVF methodologies, ultimately improving the efficacy and accessibility of reproductive health services worldwide. This dynamic landscape positions the IVF workstations market for substantial growth in the coming years.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 LifeGlobal
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Merck KGaA
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Cook Medical
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Hologic Inc.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 K-ART Clinic
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Vitrolife AB
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Genea Biomedx
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 ReproMed Ltd.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Fertility Partners
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 CooperSurgical Inc.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 ESCO Micro Pte Ltd.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Swiss Fertility Centre
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Ferring Pharmaceuticals
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 IBSA Farmaceutici Italia Srl
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Thermo Fisher Scientific Inc.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 In Vitro Fertilization IVF Workstations Market, By End User
    • 6.1.1 Surgery Centers
    • 6.1.2 Clinics
    • 6.1.3 Hospitals
    • 6.1.4 Homecare Settings
  • 6.2 In Vitro Fertilization IVF Workstations Market, By Technology
    • 6.2.1 Time-Lapse Technology
    • 6.2.2 EmbryoScope Technology
    • 6.2.3 Closed Incubation Systems
    • 6.2.4 Sequential Media
  • 6.3 In Vitro Fertilization IVF Workstations Market, By Application
    • 6.3.1 Fertility Clinics
    • 6.3.2 Hospitals
    • 6.3.3 Research Institutes
    • 6.3.4 Cryobanks
  • 6.4 In Vitro Fertilization IVF Workstations Market, By Product Type
    • 6.4.1 Suction Pumps
    • 6.4.2 Incubators
    • 6.4.3 Oocyte Retrieval Needles
    • 6.4.4 Micromanipulator Systems
    • 6.4.5 Imaging Systems

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 In Vitro Fertilization IVF Workstations Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global In Vitro Fertilization IVF Workstations market is categorized based on

By Product Type

• Suction Pumps
• Incubators
• Oocyte Retrieval Needles
• Micromanipulator Systems
• Imaging Systems

By Application

• Fertility Clinics
• Hospitals
• Research Institutes
• Cryobanks

By End User

• Surgery Centers
• Clinics
• Hospitals
• Homecare Settings

By Technology

• Time-Lapse Technology
• EmbryoScope Technology
• Closed Incubation Systems
• Sequential Media

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• CooperSurgical Inc.
• Vitrolife AB
• Ferring Pharmaceuticals
• Merck KGaA
• Cook Medical
• IBSA Farmaceutici Italia Srl
• Thermo Fisher Scientific Inc.
• Genea Biomedx
• Hologic Inc.
• ESCO Micro Pte Ltd.
• K-ART Clinic
• LifeGlobal
• ReproMed Ltd.
• Swiss Fertility Centre
• Fertility Partners